UFSA

UFSA İlaç Sanayi ve Ticaret A.Ş. (UFSA) is a Turkish pharmaceutical company headquartered in Istanbul. It operates as part of the İbrahim Etem-Menarini Group, following the acquisition of its parent group by the Italian biopharmaceutical giant Menarini in 2001. UFSA specializes in the manufacturing, marketing, and distribution of a wide range of pharmaceutical products, with a strong focus on pain management, cardiovascular health, and anti-inflammatory treatments. Its most notable commercial product is Arveles (dexketoprofen trometamol), a widely prescribed non-steroidal anti-inflammatory drug (NSAID) used for acute and chronic pain relief.